Skip to main content
Veterinary Medicines

Nobivac Ducat Lyophilisate and solvent for suspension for injection

Authorised
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live

Product identification

Medicine name:
Nobivac Ducat Lyophilisate and solvent for suspension for injection
Nobivac Ducat
Active substance:
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Felid herpesvirus 1, strain G2620A, Live
    4.80
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Feline calicivirus, strain F9, Live
    4.60
    log10 plaque forming unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD03
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • (ID44): 1 Cardbox with 50 Bottle (Glass) with 1 Dose and 50 Bottle (Glass) with 1 millilitre(s)) (50 Dose, 50 millilitre(s))
  • (ID34): 1 Cardbox with 25 Bottle (Glass) with 1 Dose and 25 Bottle (Glass) with 1 millilitre(s)) (25 Dose, 25 millilitre(s))
  • (ID24): 1 Cardbox with 10 Bottle (Glass) with 1 Dose and 10 Bottle (Glass) with 1 millilitre(s)) (10 Dose, 10 millilitre(s))
  • (ID14): 1 Cardbox 5 Bottle (Glass) with 1 Dose and 5 Bottle (Glass) with 1 millilitre(s)) (5 Dose, 5 millilitre(s))
  • (ID45): 1 Plasticbox 5 Bottle (Glass) with 1 Dose and 5 Bottle (Glass) with 1 millilitre(s)) (5 Dose, 5 millilitre(s))
  • (ID46): 1 Plasticbox with 10 Bottle (Glass) with 1 Dose and 10 Bottle (Glass) with 1 millilitre(s)) (10 Dose, 10 millilitre(s))
  • (ID47): 1 Plasticbox with 25 Bottle (Glass) with 1 Dose and 25 Bottle (Glass) with 1 millilitre(s)) (10 Dose, 10 millilitre(s))
  • (ID48): 1 Plasticbox with 50 Bottle (Glass) with 1 Dose and 50 Bottle (Glass) with 1 millilitre(s)) (10 Dose, 10 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 10235
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0207/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/02/2022

Summary of Product Characteristics

English (PDF)
Published on: 13/03/2023
Download

Package Leaflet

English (PDF)
Published on: 16/03/2023
Download